<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129598">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01414959</url>
  </required_header>
  <id_info>
    <org_study_id>Dori_MD_ICU</org_study_id>
    <nct_id>NCT01414959</nct_id>
  </id_info>
  <brief_title>Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients</brief_title>
  <official_title>Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will measure the pharmacokinetics of doripenem in skeletal muscle,
      subcutaneous adipose tissue, bronchoalveolar lavage and plasma of intubated intensive care
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: microdialysis, blood sampling, bronchoalveolar lavage
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Pneumonia</condition>
  <condition>Abdominal Infection</condition>
  <condition>Urinary Tract Infection</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma broncheoalvoeolar lavage microdialysates
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        intubated patients, intensive care
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  endotracheal intubation; pneumonia or complicated abdominal infection or complicated
             urinary tract infection

        Exclusion Criteria:

          -  allergy to doripenem, hemodialysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus Zeitlinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Universit of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>markus zeitlinger, md</last_name>
    <phone>0043140400</phone>
    <phone_ext>2981</phone_ext>
    <email>markus.zeitlinger@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Med. Univ. of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>robert sauermann, md</last_name>
    </contact>
    <contact_backup>
      <last_name>markus zeitligner, md</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <lastchanged_date>September 5, 2011</lastchanged_date>
  <firstreceived_date>August 10, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Markus Zeitlinger</investigator_full_name>
    <investigator_title>Professor Dr.</investigator_title>
  </responsible_party>
  <keyword>intensive care patient</keyword>
  <keyword>intubation</keyword>
  <keyword>(please change wording as you like!)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
    <mesh_term>Intraabdominal Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
